You are here: Industry Insights > Carcinogen

News List

Novartis is first to recall generic Zantac after confirming suspected carcinogen fiercepharma
September 26, 2019
The Swiss drugmaker said it has not received any reports of adverse events related to use of the product as part of this recall but acknowledged NDMA is suspected of causing cancer.
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen drugs
September 20, 2019
Novartis, the maker of a generic form of Zantac, said Wednesday it will stop selling the medicine after investigations suggested that generic and branded versions contain a known carcinogen.
NDMA discovered in samples of ranitidine medicines europeanpharmaceuticalreview
September 17, 2019
The EMA and the FDA are investigating some ranitidine medicines after they were found to contain NDMA, a probable human carcinogen.
Zantac May Contain Small Amounts of Known Carcinogen drugs
September 16, 2019
A substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac...
Blood pressure and heart medication recalled by MHRA in UK europeanpharmaceuticalreview
April 16, 2019
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine…
The valsartan carcinogen mess taught pharma a surprise manufacturing lesson. Will 2019 bring more? fiercepharma
December 20, 2018
Industry wisdom is that there is nothing new to learn about tablet making. Drugmakers have been doing it essentially the same way for more than 100 years.
Teva Announces Recall americanpharmaceuticalreview
November 29, 2018
Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan.....
EU regulators blast China’s Zhejiang Huahai over valsartan API mess fiercepharma
September 29, 2018
The European Medicines Agency has piled onto China’s Zhejiang Huahai, finding its manufacturing out of compliance for the valsartan API that has been recalled globally after being found to contain a suspected carcinogen.
A Carcinogen Lurking around is the Thing in Common Use Yefenghong
August 14, 2018
There has been a large number of studies exploring the possible toxic effects of TCS on living things. The article provides some help for common health management.
Aldehydes Dominant Carcinogen in Tobacco Smoke drugs
July 30, 2018
Aldehydes are the major carcinogens in tobacco smoke, according to a study published online June 18 in the Proceedings of the National Academy of Sciences.

Previous page 1 2 Next page